Literature DB >> 23924471

Neuroprotective effect of AG490 in experimental traumatic brain injury of rats.

Ai-ling DU1, Tai-ling Ji, Bin Yang, Jian-feng Cao, Xing-guang Zhang, Yu Li, Shun Pan, Bo Zhang, Zhen-bo Hu, Xian-wei Zeng.   

Abstract

BACKGROUND: Traumatic brain injury (TBI) is a major cause of death and disability in children and young adults worldwide. Therefore, we investigated the role of AG490 in regulating brain oedema, expression of CD40 and neurological function after TBI.
METHODS: Sprague Dawley rats (n = 240) were randomly divided into a sham operation group, TBI+saline group and TBI+AG490 (JAK/STAT inhibitor) group. Members of each group were euthanized at 6, 12, 24 or 72 hours after injury. Neurological severity score (NSS) was used to evaluate the severity of neurological damage. Brain water was quantitated by wet/dry weight method. The expression of CD40 was assessed by flow cytometry.
RESULTS: In both the TBI+saline group and the TBI+AG490 group, the brain water content was elevated after TBI, reached a peak at 24-hour and remained high for the rest of the period investigated; the expression of CD40 reached a peak 24 hours after TBI; the NSS was elevated after TBI and then decreased after 6 hours. Elevations in the level of CD40, degree of brain edema and NSS after TBI were significantly reduced in TBI+AG490 group.
CONCLUSION: Inhibition of the JAK/STAT signalling pathway reduces brain oedema, decreases the expression of CD40 and exerts neuroprotective effects after TBI.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23924471

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  5 in total

1.  Tractable synthesis of multipurpose screening compounds with under-represented molecular features for an open access screening platform.

Authors:  Felix Wilde; Edgar Specker; Martin Neuenschwander; Marc Nazaré; Anja Bodtke; Andreas Link
Journal:  Mol Divers       Date:  2014-04-01       Impact factor: 2.943

2.  Substituted tetrazoles as multipurpose screening compounds.

Authors:  Nicole Rüger; Georg Michael Fassauer; Christian Bock; Thomas Emmrich; Anja Bodtke; Andreas Link
Journal:  Mol Divers       Date:  2016-12-27       Impact factor: 2.943

Review 3.  CD40-CD40L in Neurological Disease.

Authors:  Heather D Ots; Jovanna A Tracz; Katherine E Vinokuroff; Alberto E Musto
Journal:  Int J Mol Sci       Date:  2022-04-08       Impact factor: 6.208

4.  Repetitive hyperbaric oxygenation attenuates reactive astrogliosis and suppresses expression of inflammatory mediators in the rat model of brain injury.

Authors:  Irena Lavrnja; Ana Parabucki; Predrag Brkic; Tomislav Jovanovic; Sanja Dacic; Danijela Savic; Igor Pantic; Mirjana Stojiljkovic; Sanja Pekovic
Journal:  Mediators Inflamm       Date:  2015-04-20       Impact factor: 4.711

5.  Recombinant Human Erythropoietin Protects Myocardial Cells from Apoptosis via the Janus-Activated Kinase 2/Signal Transducer and Activator of Transcription 5 Pathway in Rats with Epilepsy.

Authors:  Bao-Xin Ma; Jie Li; Hua Li; Sui-Sheng Wu
Journal:  Curr Ther Res Clin Exp       Date:  2015-08-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.